Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Pathway Analysis Tools to RNAi

NEW YORK, Jan. 24 (GenomeWeb News) - GeneGo has licensed its pathway analysis database and software to RNAi of Japan, the St. Joseph, Mich.-based company said today. The two companies also plan to collaborate to integrate RNA interference with GeneGo's technology.


RNAi, GeneGo's first Japanese customer, plans to use GeneGo's MetaCore platform in its RNA interference-based drug discovery research.


MetaCore, which includes a pathway database, allows researchers to analyze different types of experimental data and visualize tissue-specific networks.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.